As early as 2015, Qilu Pharmaceutical Group and Jawa-Huicheng successfully established a DSCSA compliance traceability system, setting a precedent for the operation of serialization systems in Chinese factories.

Jawa's traceability products and services comprehensively support Qilu Group's diverse business segments, including both domestic and export operations. As a result, Jawa has emerged as a strategic service provider for Qilu Pharmaceutical's export drug serialization.
As of the end of 2023, Qilu Group's pharmaceutical products have been exported to over 90 countries and regions worldwide, with approximately 40 products having the highest market share globally or in the countries where they are sold, benefiting approximately 1 billion patients worldwide.
Jawa’s NT-Track serialization platform is the L4 part of the manufacturer traceability system, responsible for important functions such as connection, collaboration, and product lifecycle traceability management.
The Jawa system efficiently manages various processing factories within the enterprise. It allows for the allocation of serial numbers (SN) to different factories based on production plans. After production is completed, the production data can be uploaded to the L4 system through the platform's interface. The platform supports data uploads for various EPCIS events and is compatible with communication protocols such as HTTPS, SOAP, AS2, and SFTP. Additionally, the system operates in silent management mode and features plugin publishing capabilities.
Jawa expert team provides consultation services to help Qilu achieve low-cost and efficient integration with L4 platforms for multinational clients and wholesalers.